Skip to main content
Premium Trial:

Request an Annual Quote

BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests

NEW YORK – DiaSorin Molecular said on Wednesday that it has received additional funding from the US Health and Human Services Biomedical Advanced Research and Development Authority to validate its Simplexa COVID-19 Direct kit and Simplexa COVID-19 & Flu A/B Direct kit.

The funding will also be used to submit the kits to the US Food and Drug Administration for 510(k) clearance. Both tests are for use with DiaSorin's Liaison MDX platform.

BARDA said the total BARDA contract is for about $4 million. In March, Cypress, California-based DiaSorin Molecular, a subsidiary of DiaSorin, received $679,000 in BARDA funding for the validation of the Simplexa COVID-19 Direct kit for Emergency Use Authorization from the FDA, which was issued later that month. Test results are provided in about one hour.

DiaSorin Molecular noted that the Simplexa COVID-19 Direct kit detects SARS-CoV-2 RNA, including in the new variants of the coronavirus recently isolated in the UK and South Africa. 

The Simplexa COVID-19 & flu A/B Direct test provides results in about 90 minutes and is expected to be available for use during the 2021 influenza season

The two tests use a nasopharyngeal or nasal swab, or a bronchial lavage sample.

The Scan

Gene Linked to Alkaline Sensitivity in Plants Identified

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.